| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT
NL NO PL PT RO RS SE SI SK SM TR |
|
Designated Extension States: |
|
BA |
|
Designated Validation States: |
|
GE KH MA MD TN |
| (30) |
Priority: |
01.12.2023 US 202363605259 P
|
| (71) |
Applicant: Sigilon Therapeutics, Inc. |
|
Indianapolis, Indiana 46285 (US) |
|
| (72) |
Inventors: |
|
- BANDUKWALA, Hozefa
Indianapolis, Indiana 46206-6288 (US)
- EFANOV, Alexander
Indianapolis, Indiana 46206-6288 (US)
- IVASHCHENKO, Christine
Indianapolis, Indiana 46206-6288 (US)
- JING, Enxuan
Indianapolis, Indiana 46206-6288 (US)
- JING, Ying
Indianapolis, Indiana 46206-6288 (US)
- KELLY, Olivia
Indianapolis, Indiana 46206-6288 (US)
- LAMBALOT, Matthew T.
Indianapolis, Indiana 46206-6288 (US)
- LAWSON, Tristan Fabian Samuel
Indianapolis, Indiana 46206-6288 (US)
- MCCLATCHEY, JR., Penn Mason
Indianapolis, Indiana 46206-6288 (US)
- MOZDZIERZ, Nicholas Joseph
Indianapolis, Indiana 46206-6288 (US)
- SHI, Xiaoying
Indianapolis, Indiana 46206-6288 (US)
- THOMAS, Melissa
Indianapolis, Indiana 46206-6288 (US)
|
| (74) |
Representative: Eli Lilly and Company Limited |
|
8 Arlington Square West
Downshire Way Bracknell, Berkshire RG12 1PU Bracknell, Berkshire RG12 1PU (GB) |
|